维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Awada C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Dietary phytosterol inhibits the growth and metastasis ofM DA-M B-231 human breast cancer cells grow in SCID mice 显示文摘	Awada B Downie A Fink C S	2000	Anticancer Research2000，20，2：	1
2	Phase 2 results ofXL184in a cohort of patients(PTS)with advanced non-smallcell lung cancer(NSCLC)显示文摘	Yasenchak C Nackaerts K Awada A	2010	Ejc Supplements2010，8，7：	1
3	Elastography in the assessment of sentinel lymph nodes prior to dissection显示文摘	Tourasse C Denier JF Awada A	2012	Eur J Radiol2012，81，11：	1
4	Elastography in the assess- ment of sentinel lymph nodes prior to dissection 显示文摘	Tourasse C D6nier JF Awada A	2012	Eur J Radiol2012，，：	1
5	Cinnamon im- proves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome显示文摘	Couturier K Batandier C Awada M	2010	Arch Biochem Biophys2010，50，1：	1
6	The oral mTOR inhibitor RADOOl (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics 显示文摘	Awada A Cardoso F Fontaine C	2008	EurJ Cancer2008，44，1：	1
7	Molecular targeted therapy in prevalent tumors:Learning from the past and future perspectives 显示文摘	Metzger-Filho O Moulin C Awada A	2010	Curr Clin Pharmacol2010，5，3：	1
8	A multicentre dose-escalating study ofcabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase l/II study 显示文摘	Villanueva C Awada A Campone M	2011	European journal of cancer2011，47，7：	1
9	Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anticancer agents: a review of clinical trials 显示文摘	TAKIMOTO C H AWADA A	2008	Can Chem Phar-maco2008，61，4：	1
10	Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials 显示文摘	TAKIMOTO C H AWADA A	2008	Cancer Chemother Pharmacol2008，61，4：	1
11	Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome显示文摘	Couturier K Batandier C Awada M	2010	Arch Biochem Biophys2010，501，1：	1
12	PhaseⅢopen-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘	Kaufman PA Awada A Twelves C	2015	J Clin Oncol2015，33，6：	1
13	The oral m TOR inhibitor RAD001(everolimus)in combination with letrozole in patients with advanced breast cancer:results of a phase I study with pharmacokinetics显示文摘	Awada A Cardoso F Fontaine C	2008	Eur J Cancer2008，44，1：	1
14	Potential involve ment of the IL-33-ST2 axis in the pathogenesis of pri mary Sjogren's syndrome显示文摘	Awada A Nicaise C Ena S	2014	Annals of the Rheumatic Diseases2014，73，6：	1
15	Phase HI open-la-bel randomized study of eribulin mesylate versus capecit-abine in patients with locally advanced or metastatic bre-ast cancer previously treated with an anthracycline and ataxane显示文摘	Kaufinan PA Awada A Twelves C	2015	J Clin2015，33，6：	1
16	Phase m open-label randomized study of eribulin mesylate versus capecitabine in pa- tients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘	Kaufman PA Awada A Twelves C	2015	J Clin Oncol2015，33，6：	1
17	Basolateral secretion of WntSa in polarized epithelial cells is required for apical lumen formation显示文摘	Yamamotol H Awada C Matsumoto S	2015	J Cell Science2015，128，5：	1
18	Phase I study of Carzelesin (U- 80, 244) given (4-weekly) by intravenous bolus schedule显示文摘	Awada A Punt C J Piccat M J	1999	Br J Cancer1999，79，910：	1
19	The oral mTOR inhibitor RAD001 (evemlimus) in combination with letrozole in patients with advanced breast cancer: Results of a phase 1 study with pharmaeokinetics显示文摘	AWADA A CARDOSO F FONTAINE C	2008	Euro J Can2008，44，1：	1
20	A multicen- tre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer pro- gressing after anthracycline and taxane treatment: a phase Ⅰ/Ⅱ study显示文摘	VILLANUEVA C AWADA A CAMPONE M	2011	Eur JCancer2011，47，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示